BOSCARO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.207
EU - Europa 2.842
AS - Asia 710
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 1
Totale 9.772
Nazione #
US - Stati Uniti d'America 6.204
UA - Ucraina 817
IE - Irlanda 397
DE - Germania 363
SE - Svezia 347
DK - Danimarca 316
TR - Turchia 299
IT - Italia 234
FI - Finlandia 174
KR - Corea 166
SG - Singapore 140
GB - Regno Unito 131
CN - Cina 89
BE - Belgio 32
FR - Francia 13
IN - India 8
RU - Federazione Russa 8
EU - Europa 6
AU - Australia 3
CA - Canada 3
IR - Iran 3
JP - Giappone 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
PL - Polonia 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
Totale 9.772
Città #
Chandler 857
Jacksonville 830
Des Moines 705
Fairfield 423
Dublin 396
Ashburn 348
Boardman 279
Wilmington 251
New York 239
Woodbridge 230
Ann Arbor 179
Seattle 179
Lawrence 168
Princeton 168
Houston 158
Cambridge 145
San Mateo 137
Centro 64
San Diego 55
Brussels 32
Los Angeles 32
Turin 31
Washington 25
Norwalk 23
Beijing 16
Civitanova Marche 15
Falls Church 15
Helsinki 9
Auburn Hills 7
Guangzhou 6
London 6
Redmond 6
Wuhan 6
Mumbai 5
Rome 5
Ancona 4
Izmir 4
Kilburn 4
Milan 4
Salerno 4
Shanghai 4
Brugherio 3
Filottrano 3
Frankfurt am Main 3
New Bedfont 3
Ottawa 3
Porto San Giorgio 3
Pune 3
Siena 3
Yiwu 3
Chengdu 2
Edinburgh 2
Fars 2
Hangzhou 2
Hanover 2
Jinhua 2
Montignoso 2
Moscow 2
Munich 2
Otemae 2
Padova 2
Pescara 2
Phoenix 2
Porto 2
Quanzhou 2
Shenzhen 2
Sofia 2
Stockholm 2
Tappahannock 2
Warsaw 2
Yuncheng 2
Abidjan 1
Acton 1
Adelaide 1
Amsterdam 1
Ascoli Piceno 1
Auckland 1
Borås 1
Brescia 1
Brisbane 1
Chelyabinsk 1
Chiswick 1
Christchurch 1
Copenhagen 1
Dalian 1
Falkenstein 1
Fayetteville 1
Florence 1
Foresto 1
Gatchina 1
Genova 1
Gillingham 1
Gorizia 1
Greve in Chianti 1
Heze 1
Hollywood 1
Hounslow 1
Isfahan 1
Jiaxing 1
Jinan 1
Totale 6.172
Nome #
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 124
Persistent psychological distress in patients treated for endocrine disease. 120
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 118
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 116
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 108
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 99
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 96
Multiple endocrine neoplasia type 1 and adrenal lesions 89
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 88
Adrenal incidentaloma: surgical update. 88
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 87
Psychosocial impairment in patients treated for pituitary disease: a controlled study 86
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 86
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 85
GH secretagogues and hypothalamo-pituitary-adrenal axis 84
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 84
Diagnosis and complications of Cushing's syndrome: a consensus statement 83
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 82
Aldosterone as a cardiovascular risk factor. 82
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 82
Personality characteristics and quality of life in patients treated for Cushing's syndrome 81
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 79
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 79
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 77
Adipose cell-adrenal interactions: current knowledge and future perspectives. 77
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 77
Cushing's syndrome 76
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 76
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 75
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 74
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 73
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 73
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 73
Diagnosis and management of adrenal incidentalomas. 72
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 71
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 71
Self image and quality of life in acromegaly 71
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 71
Consideration in diagnosis of Cushing's syndrome 70
Coenzyme Q10 and male infertility 69
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. 69
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 68
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 68
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 68
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 68
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 68
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 68
Diagnosis of primary aldosteronism: from screening to subtype differentiation 67
Left ventricular structure and functional characteristic in Cushing's syndrome 67
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 67
Effect of natural early menopause on bone mineral density. 66
Endocrine aspects of cancer gene therapy. 66
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 66
Comment - Is there a role for low doses of mitotane (o, p'-DDD) as adjuvant therapy in adrenocortical carcinoma? 65
Chemical-physical properties of lipoproteins in anorexia nervosa. 65
Gene therapy for thyroid cancer. 65
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 65
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 64
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. 64
Expanding role of AMPK in endocrinology 64
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 64
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 64
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 63
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 63
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 63
Effect of glucocorticoids on adiponectin:a study in healthy subjects and Cushing's syndrome 63
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 62
Adrenal incidentaloma: effects on bone metabolism. 62
New treatment guidelines on Cushing's disease. 62
Bone health and aldosterone excess 62
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 62
Genetic mutations in thyroid carcinoma 61
Chemotherapy at the end of life: an open question. 61
Hormonal responses during various phrases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. 61
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 61
Adrenocortical carcinoma:experience in 45 patients. 61
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 60
Foreword. Glucocorticoid-induced osteoporosis. 59
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 59
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 59
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 59
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 59
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 59
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 59
The diagnosis of Cushing' s syndrome : atypical presentations and laboratory shortcomings 58
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 58
Can the ISO9000 quality assessment be applied to the practice of medical oncology? 57
Prevalence and natural history of adrenal incidentalomas. 57
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 57
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 57
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 57
Risk factors and long-term follw-up of adrenal incidentalomas. 56
La nutraceutica nell’infertilità maschile. 56
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 56
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 55
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma 55
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 55
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 54
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 54
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 54
Totale 7.064
Categoria #
all - tutte 42.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 0 15
2019/2020943 5 4 170 4 170 14 169 5 177 2 6 217
2020/20212.066 86 265 404 22 236 79 223 93 228 115 231 84
2021/20221.131 50 239 9 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.318 254 40 72 233 229 303 18 49 0 32 9 79
Totale 9.861